The New York Genome Center has appointed Robert Darnell to president and scientific director (see story, this issue). He will also join the board of directors. Nancy Kelley, the center's founding executive director and a board member, has also taken on the role of chief operating officer.
Darnell will maintain his current roles as Heilbrunn Professor of Cancer Biology at Rockefeller University and an investigator at the Howard Hughes Medical Institute. Additionally, he is an adjunct attending physician at Memorial Sloan-Kettering Cancer Center. He holds a BA in biology and chemistry from Columbia University and an MD and PhD from Washington University School of Medicine.
Susan Celniker has been named an AAAS fellow for her work in genomics and genetics, in particular for genomic analysis of Drosophila and discovering novel gene structures and transcript complexity.
She heads the Life Sciences Division's Department of Genome Dynamics at Lawrence Berkeley National Laboratory and is also the codirector of the Drosophila Sequencing Program.
She holds a bachelor's degree from Pitzer College in Los Angeles and a PhD from the University of North Carolina.
Illumina has appointed Robert Epstein to its board of directors. Epstein is an epidemiologist. Previously, he was chief R&D officer and president of Medco-UBC. He has also served as Medco's chief medical officer, is the former president of the International Society of Pharmacoeconomics and Outcomes Research, and has served on the board of directors of the Drug Information Association and the International Society of Quality of Life.